How insulin sensitivity affects metformin's ability to reduce age-related inflammation
Official title: The impact of insulin sensitivity on the potential of metformin to delay age-related inflammation
Funded at University of Kentucky · NIH-11078849 · Data updated 2026-11-12
This study is looking at how well metformin, a common diabetes medication, can help healthy people delay inflammation as they age, especially for those who are more sensitive to insulin, so we can find out who might benefit from it before any health issues arise.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project start | August 15, 2022 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $435,187 |
| NIH project number | 5R01AG079525-04 |
| Project ID | NIH-11078849 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are healthy adults who are insulin resistant or at risk of developing age-related health issues.
✕Less likely to help
Patients who are already experiencing significant age-related health problems or chronic inflammatory diseases may not benefit from this research.
What this research studies
This research investigates how insulin sensitivity influences the effectiveness of metformin in delaying age-related inflammation, which can impact overall health as we age. By analyzing samples from a previous trial, the study aims to identify characteristics of healthy individuals who might benefit from metformin before they develop age-related health issues. The research will focus on understanding the relationship between metabolic health and inflammation, particularly looking at cytokine profiles that may indicate inflammation levels. This could help in determining the best candidates for metformin treatment to enhance healthspan.
Why it matters
Potential benefit: If successful, this research could help identify individuals who would benefit from metformin to prevent age-related inflammation and improve their overall health as they age.
How similar studies have gone: Previous research has shown promising results in using metformin for metabolic health improvements, suggesting potential for success in this novel approach.
Where this research is happening
-
University of Kentucky
Lexington, United States Active
Researchers
- Principal investigator: Nikolajczyk, Barbara — University of Kentucky
- Study coordinator: Nikolajczyk, Barbara
Related research
Other NIH-funded projects on the same topics.
-
How clock-watching lifestyle affects fats, blood vessels, and insulin in night-shift workers
This study looks at how being awake and active at night changes lipids in the blood and muscle and what that means for blood vessel function and insulin in adults who work night shifts.
-
How bile acids affect insulin and metabolism in humans
A study using humanized mouse models and human cell systems will explore how a specific group of bile acids (12HBAs) influence insulin signaling and metabolic health in adults.
-
Placental miRNAs and insulin sensitivity in pregnancy
This grant explores whether tiny molecules from the placenta help control how the mother’s body handles insulin during pregnancy, with potential implications for gestational diabetes.
-
Understanding how fat tissue changes affect insulin health
This grant supports a clinician-scientist to explore how fat tissue in adults with obesity influences insulin sensitivity using human data and advanced analyses.
-
Regulation of a new adipokine that improves insulin sensitivity
A scientist-led study will explore how a newly found adipokine called NRN1 helps fat tissue control insulin and glucose in adults with obesity and type 2 diabetes.
-
Understanding how lipids affect blood vessels and insulin in night-shift workers
A study will look at how specific fats circulating in the blood and in tissues relate to blood vessel function and insulin sensitivity in adults who work night shifts.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.